The U.S. Food and Drug Administration granted Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) an emergency approval of its Ebola test. The company made the disclosure today. The emergency approval comes at a time when Ebola continues to cause havoc in West Africa where thousands of people have already died of the diseases while others taken ill. The virus has also been spreading to the U.S. and Europe mostly through the aid worker returning from West Africa region.
Roche’s FDA approved Ebola test can be used in patients that have shown symptoms of Ebola virus. It can also be used to test Ebola in patients that have had an encounter with risk factors, including those that may have traveled to the epicenter of the current Ebola outbreak in West Africa.